J
Juan Pablo Arab
Researcher at Pontifical Catholic University of Chile
Publications - 180
Citations - 3677
Juan Pablo Arab is an academic researcher from Pontifical Catholic University of Chile. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 109 publications receiving 1772 citations. Previous affiliations of Juan Pablo Arab include Mayo Clinic & Universidad del Desarrollo.
Papers
More filters
Journal ArticleDOI
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
TL;DR: Current available data on the relationships of bile acids to NAFLD and the potential for therapeutically targeting bile‐acid‐related pathways to address this growing world‐wide disease are summarized.
Journal ArticleDOI
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
TL;DR: A better understanding of NAFLD/NASH pathogenesis is crucial for the design of new and efficient therapeutic interventions and is summarized in the present review.
Journal ArticleDOI
Advancing the global public health agenda for NAFLD: a consensus statement.
Jeffrey V. Lazarus,Henry E. Mark,Quentin M. Anstee,Juan Pablo Arab,Rachel L. Batterham,Laurent Castera,Helena Cortez-Pinto,Javier Crespo,Kenneth Cusi,M. Ashworth Dirac,Sven Francque,Jacob George,Hannes Hagström,Terry T-K Huang,Mona H Ismail,Achim Kautz,Shiv Kumar Sarin,Rohit Loomba,Veronica Miller,Philip N. Newsome,Michael Ninburg,Ponsiano Ocama,Vlad Ratziu,Mary E. Rinella,Diana Romero,Manuel Romero-Gómez,Jörn M. Schattenberg,Emmanuel Tsochatzis,Emmanuel Tsochatzis,Luca Valenti,Luca Valenti,Vincent Wai-Sun Wong,Yusuf Yilmaz,Zobair M. Younossi,Shira Zelber-Sagi +34 more
TL;DR: In this paper, a global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved.
Journal ArticleDOI
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.
Anand V. Kulkarni,Pramod Kumar,Harsh Vardhan Tevethia,Madhumita Premkumar,Juan Pablo Arab,Roberto Candia,Rupjyoti Talukdar,Mithun Sharma,Xiaolong Qi,Padaki Nagaraja Rao,Duvvuru Nageshwar Reddy +10 more
TL;DR: The incidence of elevated liver chemistries and the presence of pre‐existing chronic liver disease (CLD) have been variably reported in COVID‐19.
Journal ArticleDOI
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
TL;DR: This review summarizes the current knowledge about the role of gut microbiota in the pathogenesis of chronic liver diseases and portal hypertension and describes a “chicken and egg” situation, where translocation increases portal pressure, and vice versa.